Skip to main content
. Author manuscript; available in PMC: 2020 Jan 1.
Published in final edited form as: J Thromb Haemost. 2018 Dec 10;17(1):113–125. doi: 10.1111/jth.14330

Fig. 6: Effect of TGM2 deficiency on CCl4-induced hepatic fibrinogen deposition.

Fig. 6:

Wild-type and TGM2−/− mice were treated with CCl4 or vehicle for 6 weeks, and hepatic fibrin(ogen) deposition was assessed 3 days after the last injection. (A) Representative photomicrographs (4x virtual objective) of labeling of fibrin(ogen) and quantitation of positive area. HMW cross-linked Fibα (B) and Fibγ (C) was detected in liver tissues. Data are presented as mean + SEM (n=5 mice per group). * p < 0.05 compared to vehicle-treated mice (A and D), or to wild-type CCl4-treated mice (C).